Egetis is an innovative, unique, and integrated pharmaceutical drug development company, focusing on projects in late-stage development for treatment of serious rare/niche diseases with significant unmet medical needs in the orphan drug segment

Calendar and upcoming reports

May 6, 2021

Erik Penser bank- Commercialization of pharmaceuticals

May 25, 2021

ABGSC Life Science Summit

August 19, 2021

Interim report April-June

September 1-2, 2021

Pareto healthcare conference

November 4, 2021

Interim report July-September

Share

Twitter
LinkedIn

Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: info@egetis.com